Rapid maxillary expansion (RME) expands the maxillary dentition laterally and improves nasal airway obstruction. However, the incidence of nasal airway obstruction improvement after RME is approximately 60 percent. This study, published online in May 2023 in the American Journal of Orthodontics and Dentofacial Orthopedics, aimed to clarify the beneficial effects of RME on nasal airway obstruction in specific pathologic nasal airway diseases (nasal mucosa hypertrophy and obstructive adenoids) using computer fluid dynamics.
Sixty subjects (21 boys; mean age 9.1 years) were divided into three groups according to their nasal airway condition (control, nasal mucosa hypertrophy, and obstructive adenoids), and those requiring RME had cone-beam computed tomography images taken before and after RME. These data were used to evaluate the nasal airway ventilation condition (pressure) using computer fluid dynamics and measure the cross-sectional area of the nasal airway.
The cross-sectional area of the nasal airway significantly increased after RME in all 3 groups. The pressures in the control and nasal mucosa groups significantly reduced after RME but did not change significantly in the adenoid group. The incidence of improvement in nasal airway obstruction in the control, nasal mucosa, and adenoid groups was 90.0%, 31.6%, and 23.1%, respectively.
The incidence of improvement in nasal airway obstruction after RME depends on the nasal airway condition (nasal mucosa hypertrophy and obstructive adenoids). In patients with nonpathological nasal airway conditions, the obstruction may be sufficiently improved with RME. Furthermore, to some extent, RME may be effective in treating nasal mucosa hypertrophy. However, because of obstructive adenoids, RME was ineffective in patients with nasal airway obstruction.
Highlights
For more information: "Does rapid maxillary expansion improve nasal airway obstruction? A computer fluid dynamics study in patients with nasal mucosa hypertrophy and obstructive adenoids."
Pediatric dentistry 29 April 2026
Exploration and innovative application of digital technology in pediatric dentistry
Pediatric dentistry treats patients aged 0-18 years, encompassing the characteristics of general dentistry.
Pediatric dentistry 14 April 2026
Comparison between dexmedetomidine and esketamine in pediatric dentistry surgery
Dexmedetomidine (D) and esketamine (K) are used for the sedation of pediatric dental surgery. This study was designed to compare the effect of intranasal D and K in producing moderate sedation for...
Existing studies on adverse events (AEs) in pediatric dentistry have been limited in scope.
Products 13 January 2026
Revolutionizing Pediatric Dentistry with Dr. Josh Solomon: SDI Stela & Bioclear Insights
Join pediatric dentist Dr. Josh Solomon as he discusses the cutting-edge SDI Stela self-curing composite system and the Bioclear matrix system, and how these products are transforming Class II...
USA 07 June 2026 - 30 November -0001
ICOI World Congress USA 2026: Event Preview and Professional Highlights
The ICOI World Congress USA 2026 will take place from August 13, 2026 to August 15, 2026 in TBD, USA, offering dental professionals a focused environment for continuing education, clinical updates...
Edra Professional Books 06 June 2026
Understanding Dental Insurance: A Practical Reference for Dental Professionals
Understanding Dental Insurance is an Edra professional dentistry reference focused on clinical practice, education and treatment planning.
New initiative invites dentists to experience DEXIS’ most advanced AI yet, built on scale, speed, and clinical trust.
News 05 June 2026
(Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/C
News 05 June 2026
(Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced that its Board of Directors has elected Will